NIOX Group plc
Director/PDMR Shareholding
4 December 2025
NIOX Group plc announces that on 3 December 2025 Sarah Duncan, Chief Financial Officer, purchased 5,522 Ordinary Shares at a price of 70.64 pence per share.
Following this purchase, Sarah Duncan holds a total of 5,522 Ordinary Shares (0.001% of the issued share capital of the Company).
Additional detail is provided below in accordance with the requirements of UK MAR.
-Ends-
|
For further information, please contact: |
|
|
NIOX Group plc Rebecca Clayton-Wherity, Company Secretary |
+44 (0) 3303 309 356
|
|
Singer Capital Markets (Nominated Adviser & Broker) Jen Boorer / James Fischer / James Todd
|
+44 (0) 20 7496 3000 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name: |
Sarah Duncan |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/Status: |
Chief Financial Officer |
|
|
b) |
Initial Notification/Amendment: |
Initial Notification |
|
|
3 |
Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor |
||
|
a) |
Name: |
NIOX Group plc |
|
|
b) |
LEI: |
2138006YAT138TOGA556 |
|
|
4. |
Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. |
||
|
a) |
Description of the financial instrument: Identification code: |
Ordinary Shares of 0.08p each GB00BJVD3B28 |
|
|
b) |
Nature of the transaction: |
Purchase of Ordinary Shares |
|
|
c) |
Price(s) and volume(s): |
Price(s) |
Volume(s) |
|
70.64p |
5,522 |
||
|
d) |
Aggregated information - Aggregated volume
- Price |
N/A - single transaction |
|
|
e) |
Date of the Transaction: |
3 December 2025 |
|
|
f) |
Place of the Transaction: |
London Stock Exchange |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
